CD14 and cancer: Elevation of CD14+HLA-DR−/low cells has been described as an indicator of poor prognosis, in terms of patient survival [29], increased metastasis and poor response to chemotherapy [30], whereas elevation of HLA-DR in tumors has been associated with favorable outcomes in several cancer types [17, 19, 20].